Company page
Pharmigene, Inc.
Pharmigene, Inc. is a public company traded on the Taiwan stock market under the ticker 7595. The company has a market capitalization of approximately 13.06 million USD. Pharmigene focuses on developing innovative solutions in the biotechnology sector.
- Ticker
- 7595:TPEX
- Asset type
- Stock
- Market cap
- $13.1M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Generic
- Exchange
- TPEX
- Currency
- TWD